NCT01739361View on ClinicalTrials.gov

Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Severe Sepsis
Interventions
DRUG

Acetaminophen

DRUG

placebo

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT01739361 - Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis | Biotech Hunter | Biotech Hunter